PROCESS FOR DETERMINING SUBSTRATE OR ENZYMATIC ACTIVITY

Abstract: A process for quantitavely determining a substrate or enzyme activity in a body fluid can be carried out with high accuracy without any influence of interfering substance by adding to a sample a first reagent solution comprising 2-naphthol or a derivative thereof, peroxidase, an oxidase, and if necessary one or more substances for producing a substrate or used as substrates for the oxidase and the like, adding to the resulting mixture a second reagent solution comprising 4-amino-antipyrine, a developer, and an enzyme necessary for producing the same substance as giving an error to the determination of substrate, or one or more sub­ stances used as substrates for the enzyme to be determined, followed by colorimetrical determination.

Description: PROCESS FOR DETERMINING SUBSTRATE OR ENZYMATIC ACTIVITY This invention relates to a process for quantitatively determining a substrate or enzymatic activity in a body fluid. More particularly, this invention relates to a process for quantitatively determining a substrate or enzymatic activity after removing influences of a substance which is present in a body fluid and gives an error to the determination. Recently, in the field of clinical examinations, there have widely been employed processes for measuring hydrogen peroxide produced by treating a substrate or a substance produced by an enzymatic reaction of a substrate with an oxidase as a process for measuring a component in a body fluid. As a process for measuring hydrogen peroxide, there has mainly been employed a process comprising adding to a sample 4-aminoantipyrine and a phenol derivative, a naphthol derivative or an aniline derivative in the presence of peroxidase to produced a colored substance by oxidative condensation, followed by colorimetrical determination. But with an increase of a demand for more precise determination, there has become a problem the presence of a substance in a body fluid, said substance giving an error to the determination. For example, there were found the following substances for giving errors to the determination, that is, free glycerol in a body fluid in the determination of triglyceride, cholesterol in the determination of cholesterol ester, sarcosine in the determination of creatine or creatinine, pyruvic acid in the enzymatic activity determination of glutamate pyruvate transaminase (hereinafter referred to as "GPT") or glutamate oxaloacetate transaminase (hereinafter referred to as "GOT"), and glucose in the enzymatic activity determination of amylase. Various methods for decomposing or removing such substances as giving errors to the determination have been studied. For example, European Patent Publication No. 0054358 discloses a process for decomposing hydrogen peroxide by reacting hydrogen peroxide produced by oxidation of a free compound which gives an error to the determination with a phenol or aniline derivative in the presence of peroxidase to form non-coloring compound. Said European Patent Publication further provides a process for quantitative determination of a non-oxidizable analyte in a sample containing both said analyte and an enzymatically oxidizable derivative thereof, which comprises enzymatically oxidizing said derivative with an oxidase, decomposing hydrogen peroxide produced in the sample by said oxidase by a reaction with a phenol or aniline derivative in the presence of a peroxidase, converting the non-oxidizable analyte into a further quantity of said oxidizable derivative, and quantitatively determining said further quantity of said oxidizable derivative. In Chemical Abstracts 98:30600 m (1983), there is disclosed a process for determining a substrate or its enzymatic activity by the determination of H202 formed by reacting an oxidase with a product formed by the enzymatic reaction, characterized in that a sample is added to a first reagent containing an oxidase, peroxidase and a phenol, aniline or naphthol derivative, and the resulting mixture is mixed with a second reagent containing a coupler such as 4-aminoanitipyrine, followed by colorimetrical determination. According to these processes, a phenol or aniline derivative or a naphthol derivative is used for decomposing a substance which gives errors to the determination, but since the phenol, aniline or naphthol derivative is also used for producing a color with a coupler such as 4-aminoantipyrine, a partial consumption of the phenol, aniline or naphthol derivative for decomposing hydrogen peroxide makes it difficult to form uniform color producing conditions in the color developing reaction. On the other hand, if a large amount of the phenol, aniline or naphthol derivative is used for compensating the consumed amount for decomposing hydrogen peroxide which gives an error to the determination, the reagent blank value is undesirably raised, which results in making the determination with high accuracy impossible. It is an object of this invention to provide a process for quantitatively determining a substrate or enzymatic activity in a body fluid with high accuracy by overcoming disadvantages of the prior art processes. This invention procides a process for quantitatively determining a substrate or enzymatic activity in a body fluid which comprises adding to a sample to be measured a first reagent solution comprising 2-naphthol or a derivative thereof represented by the formula: EMI4.1 wherein R1 and R2 are independently hydrogen, a hydroxyl group, a carboxyl group or a sulfonic acid group, peroxidase, an oxidase, and if necessary one or more substances used for producing a substrate or used as substrates for oxidase or used for an enzymatic reaction of a substrate with the oxidase, so as to remove an influence of substance in the sample giving an error to the determination (an interfering substance), adding to the resulting mixture a second reagent solution comprising a coupler such as 4-aminoantipyrine, a developer selected from phenol derivatives, l-naphthol derivatives and aniline derivatives, and an enzyme necessary for producing the same substance as the interfering substance (giving an error to the determination) in the case of determining the substrate, or one or more substances used as substrates for the enzyme, the activity of which is to be determined, in the case of determining the enzymatic activity, followed by colorimetrical determination. As the substrate to be determined according to this invention, there are exemplified triglyceride, cholesterol ester, creatininine, creatine and the like. As the enzyme, the activity of which is to be determined according to this invention, there are exemplified transaminases such as GPT, GOT; amylase, and the like. According to this invention, the system containing the substance to be determined colorimetrically can be maintained under uniform conditions and there can be selected a suitable combination of color producing materials. Further, 2-naphthol or a derivative thereof represented by the formula (I) does not influence the color producing system comprising a coupler such as 4aminoantipyrine and a phenol derivative, a l-naphthol derivative or an aniline derivative. This is because the compound of the formula (I) has a higher oxidationreduction potential to be oxidized by hydrogen peroxide in the presence of peroxidase than that of the color producing material (developer) such as a phenol derivative, a l-naphthol derivative or an aniline derivative to be coupled with 4-aminoantipyrine, so that the phenol derivative, the l-naphthol derivative or the aniline derivative seems to preferentially carry out the oxidative condensation with 4-aminoantipyrine. As the compound of the formula (I), there can be used 2-naphthol, 7-hydroxy-2-naphthol, 2-naphthol-7sulfonic acid, 2-naphthol-3,6-disulfonic acid, 2naphthol-3-carboxylic acid, etc. As phenol and derivatives thereof used as developer, there can be used phenol, pchlorophenol, 2,4-dichlorophenol, p-bromophenol, o-chlorophenol, m-chlorophenol, and the like. As aniline and derivatives thereof used as developer, there can be used aniline, N,Ndimethylaniline, N,N-diethylaniline, N,N-diethyl-mtoluidine, 3-methyl-N-ethyl-N-(ss-hydroxyethyl)-aniline, N-ethyl-N- (2-hydroxy-3-sulfopropyl) -m-toluidine, 3,5dimethyl-N-ethyl-N-(2-hydroxy-3-sulfopropyl)-aniline, 3,5-dimethOxy-N-ethyl-(2-hydroxy-3-sulfopropyl)-aniline, and the like. As l-naphthol and derivatives thereof used as developer there can be used l-naphthol, l-naphthol2-sulfonic acid, l-naphthol-2-carboxylic acid, l-naphthol-8 -sulfonic acid, l-naphthol-3-sulfonic acid, l-naphthol-5-sulfonic acid, and the like. As the coupler, there can be used 4-aminoantipyrine, etc. The first reagent solution comprises a compound of the formula (I) in an amount of usually 0.01 to 10 mM, preferably 0.1 to 0.5 mM, a peroxidase in an amount of usually 0.1 - 10 units/ml, an oxidase in an amount of usually 0.05 - 20 units/ml and, if necessary one or more substances for producing a substrate for the oxidase, used as a substrate for the oxidase, or used for an enzymatic reaction of a substrate with the oxidase depending on the kind of substrate or enzyme to be determined. The second reagent solution comprises a coupler such as 4-aminoantipyrine, a developer selected from phenol and derivatives thereof, l-naphthol and derivatives thereof and aniline and derivatives thereof, and an enzyme necessary for producing the same substance as giving an error to the determination in the case of determining the substrate, or one or more substances for giving a substrate for the enzyme, the activity of which is to be determined, in the case of determining the enzymatic activity; The enzyme necessary for producing the same substance as giving an error to the determination of substrate changes depending on the kind of substrate to be determined. The substances for giving a substrate for the enzyme, the activity of which is to be determined, changes depending on the kind of enzyme to be determined its activity. The first reagent solution and the second reagent solution may further contain, respectively, one or more buffering agents, surface active agents, stabilizers, and the like additives depending on purposes. As the buffering agents, there can be used convetionally used buffer solutions. The pH of the first and second reagent solutions is usually in the range of 5 to 9. The time necessary for decomposing hydrogen peroxide with the compound of the formula (I) to form a non-coloring compound was measured as follows. To 3 ml of a Good's buffer solution having a pH 7, 10 units of peroxidase and 0.2 mM of the compound of the formula (I) were added. Subsequently, hydrogen peroxide was added to the resulting mixture so as to make the content of hydrogen peroxide 0.1 mM in the reaction sample, followed by incubation at 370C for a predetermined time. The time required for decomposing hydrogen peroxide (for discoloring) was measured by adding 0.3 mg of 4-aminoantipyrine and 3 mg of phenol to the mixture after the incubation to measure the production of color. The results are as shown in Table 1. As is clear from Table 1, the time required for discoloring is very short. Table 1 EMI8.1 <tb> <SEP> (I) <SEP> Time <SEP> required <SEP> for <tb> Compound <SEP> of <SEP> the <SEP> formula <SEP> (I) <SEP> discoloring <tb> <SEP> (sec) <tb> <SEP> X <SEP> OE <SEP> 5 <tb> <SEP> HO <tb> <SEP> HO <SEP> X <SEP> OH <SEP> 5 <tb> <SEP> 5 <tb> <SEP> HO3S <SEP> N%OH <tb> <SEP> 5 <tb> <SEP> 1OH <tb> <SEP> HO3S <SEP> 5 <tb> <SEP> NOR <tb> <SEP> g <SEP> COOH <SEP> 5 <tb> Further, there was admitted almost no influence of the compound of the formula (I) on color producing by the oxidative condensation between phenol or a derivative thereof, or aniline or a derivative thereof or 1naphthol or a derivative thereof and 4-aminoantipyrine. Such experimental results are shown in Table 2. The experiments were conducted as follows. To 3 ml of 50 mM tris-HC1 buffer solution (pH 6.5) containing a combination of developer as shown in Table 2 and peroxidase (10 units), 20 p1 of a 10 mM solution of hydrogen peroxide was added and changes of degree of coloring were measured at near the maximum absorption wavelengths of the oxidative condensation products in the absence or presence of the compound of the formula (I) in an amount of 0.5 mM as listed in Table 2. As is clear from Table 2, there was admitted no difference in the absorptions depending on the addition or nonaddition of the compound of the formula (I). In Table 2, MEHA means 3-methyl-N-ethyl-N- (f3-hydroxyethyl) -aniline and DAOS means 3,5-dimethoxy-N-ethyl-N-(2-hydroxy-3sulfopropyl)-aniline. 4-Aminoantipyrine was used in an amount of 0.4 mM and phenol and l-naphthol-2-sulfonic acid were used in an amount of 5 mM, respectively, and MEHA and DAOS were used in an amount of 1 mM, respectively. Table 2 EMI10.1 <tb> <SEP> Coupler <SEP> 4-Aminoantipyrine <tb> <SEP> Developer <SEP> l-Naphthol <tb> <SEP> Measuring <SEP> Phenol <SEP> 2-sulfonic <SEP> MEHA <SEP> DAOS <tb> <SEP> wavelength <SEP> acid <tb> (nm) <tb> Compound <SEP> of <SEP> < <SEP> 505 <SEP> 500 <SEP> 550 <SEP> 600 <tb> the <SEP> formula <SEP> (I) <tb> No <SEP> addition <SEP> 0.425 <SEP> 0.420 <SEP> 1.05 <SEP> 0.511 <tb> 2-Naphthol <SEP> 0.425 <SEP> 0.420 <SEP> 1.04 <SEP> 0.508 <tb> 2-Naphthol-7- <SEP> 0.424 <SEP> 0.419 <SEP> 1.05 <SEP> 0.507 <tb> sulfonic <SEP> acid <tb> 2-Naphthol-3- <SEP> 0.424 <SEP> 0.420 <SEP> 1.05 <SEP> 0.510 <tb> carboxylic <SEP> acid <tb> In the above, all the concentration of reagents mean final concentrations. (The same thing can be applied to the values mentioned below.) Detailed explanations will be given below on quantitative determinations of substrates or enzymatic activities. (1) Triglyceride (interfering substance: glycerol) triglyceride + 3H2O EMI10.2 glycerol + 3 fatty acid grycerol + ATP EMI10.3 glycerol-3-phosphate + ADP glycerol-3-phosphate + 2 EMI10.4 dihydroxyacetone + H O phosphate 2 2 Hz 2 + 2-naphthol (I) EMI11.1 non-coloring substance H 202 + 4-aminoantipyrine + developer EMI11.2 color development LPL: lipoprotein lipase GK: glycerol kinase ATP: adenosine-5' -triphosphate ADP: adenosine diphosphate GPO: glycerol-3-phosphate oxidase POD: peroxidase POD*: residual peroxidase (A) First reagent solution buffer solution, pH 6 to 7 2-naphthol compound (I) 0.01 to 10 mM peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. GPO) 1 to 20 units/ml substance for producing a substrate for the oxidase EMI11.3 ATP 0.5 to 10 mM GK 0.5 to 10 units/ml Mg acetate 0.3 to 3 mM (B) Second reagent solution buffer solution, pH 6 to 7 4-aminoantipyrine 0.1 to 3 mM developer 0.1 to 20 mM enzyme necessary for producing the same substance as the interfering substance EMI11.4 LPL 20 to 200 units/ml A sample such as serum is added to the first reagent solution and incubated, for example, at 370C for 5 minutes. Free glycerol present in the serum is reacted with ATP in the presence of GK and Mg++, followed by reaction with 2 in the presence of GPO to give H2021 which is reacted with the 2-naphthol compound in the presence of peroxide (POD) to give non-coloring substance. Then, the second reagent solution is added to the resulting mixture and incubated, for example, at 370C for 10 minutes to hydrolyze triglyceride in the presence of LPL to give glycerol, which is reacted to finally yield H202, the amount of which is measured colorimetrically at a wavelength of e.g. 600 nm, by a conventional method. (2) Cholesterol ester (interfering substance: cholesterol) cholesterol ester + H2O cholesterol EMI12.1 cholesterol + fatty acid cholesterol + O2 cholesterol EMI12.2 A4-cholestenon + H 202 H 202 + 2-naphthol (I) EMI12.3 non-coloring substance H 202 + 4-aminoantipyrine + developer EMI12.4 color development (A) First reagent solution buffer solution pH 6.5 to 7.5 2-naphtal 0.01 to 10 mM compound (I) peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. cholesterol 0.1 to 10 units/ml oxidase) (B) Second reagent solution buffer solution pH 6.5 - 7.5 4-aminoantipyrine 0.1 to 3 mM developer 0.1 to 20 mM enzyme necessary for producing the-same substance as the interfering substance EMI13.1 cholesterbl esterase 0.1 to 10 units/ml A sample is added to the first reagent solution and incubated to decompose the interfering substance, i.e., cholesterol, in the same manner as mentioned above, followed by addition of the second reagent solution to the resulting mixture and incubation for the colorimetrical determination in the same manner as mentioned above. (3) Creatine (interfering substance: sarcosine) creatine + H 20 creatine EMI13.2 sarcosine + urea sarcosine + H2O + O2 sarcas ine EMI13.3 H202 + HCHO + glycine H202 + 2-naphthol (I) EMI13.4 non-coloring substance H202 + 4-aminoantipyrine + developer EMI14.1 color development (A) First reagent solution buffer pH 7.5 to 8.5 2-naphthol 0.01 to 10 mM compound (I) peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. sarcosine 0.1 to 20 units/ml oxidase) (B) Second reagent solution buffer solution pH 7.5 to 8.5 4-aminoantiphyrine 0.1 to 3 mM developer 0.1 to 20 mM enzyme necessary for producing the same substance as the interfering substance EMI14.2 creatine amidinohydrase 0.1 to 100 units/ml A sample is added to the first reagent solution and incubated to decompose the interfering substance, i.e., sarcosine, in the same manner as mentioned above, followed by addition of the second reagent solution to the resulting mixture and incubation for the colorimetrical determination in the same manner as mentioned above. (4) Creatinine (interference substance: sarcosine) creatinine EMI15.1 creatine + H2O The determination can be carried out in the same manner as described in (3) creatine. (5) Glutamate pyruvate transaminase activity (interfering substance: pyruvic acid) alanine + a-ketoglutaric acid EMI15.2 glutaric + pyruvic acid acid pyruvic acid + O2 + TPP + FAD pyruvate EMI15.3 acetylphosphate H 202 + 2-naphthol (I) EMI15.4 + CO2 + HO non-coloring substance H 202 + 4-aminoantipyrine + developer EMI15.5 color development GPT: glutamate pyruvate transaminase TPP: thiamine pyrophosphate FAD: flavin adenine dinucleotide (A) First reagent solution buffer solution, pH = 7 to 8 2-naphthol compound (I) 0.01 to 10 mM peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. pyruvate 0.1 to 10 units/nI oxidase) substances used for an enzymetic reaction of a substrate with the oxidase EMI16.1 TPP 0.001 to 0.5% FAD 0.01 to 1 mM Mg acetate 0.1 to 10 mM (B) Second reagent solution buffer solution, pH = 7 to 8 4-aminoantipyrine 0.1 to 3 mM developer 0.1 to 20 mM substances used as substrates for the enzyme to be determined EMI16.2 DL-alanine 200 to.800 mM a-ketoglutaric acid 2 to 20 mM A sample is added to the first reagent solution and incubated to decompose the interfering substance, i.e., pyruvic acid, in the same manner as mentioned above, followed by addition of the second reagent solution to the resulting mixture and incubation for the colorimetrical determination in the same manner as mentioned above. (6) Glutamate oxaloacetate transaminase activity (interfering substance: oxaloacetic acid, pyruvic acid) asphatic acid + a-ketoglutaric acid EMI16.3 glutamic acid + oxaloacetic acid oxaloacetic acid EMI17.1 pyruvic acid + CO2 pyruvic acid + 2 + TPP + FAD pyruvate EMI17.2 acetylphosphate H 202 + 2-naphthol (I) EMI17.3 + CO2 + HO non-coloring substance H202 + 4-aminoantipyrine + developer EMI17.4 color development GOT: glutamate oxaloacetate transaminase OAC: oxaloacetate decarboxylase TPP: thiamine pyrophosphate FAD: flavin adenine dinucleotide (A) First reagent solution buffer solution pH 7 to 8 2-naphthol compound (I) 0.01 to 10 mM peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. 0.1 to 10 units/ml pyruvate oxidase) substances for producing a substrate for the oxidase EMI17.5 OAC 1 to 50 units/ml substances used for an enzymatic reaction of a substrate with the oxidase EMI17.6 TPP 0.001 to 0.5% FAD 0.01 to 1 mM Mg acetate 0.1 to 10 mM (B) Second reagent solution buffer solution pH 7 to 8 4-aminoantipyrine 0.1 to 3 mM developer 0.1 to 20 mM substances used as substrates for the enzyme to be determined EMI18.1 aspartic acid 50 to 400 mM a-ketoglutaric acid 2 to 20 mM A sample is added to the first reagent solution and incubated to decompose the interfering substance, i.e., oxaloacetic acid and pyruvic acid, in the same manner mentioned above, followed by addition of the second reagent solution to the resulting mixture and incubation for the colorimetrical determination in the same manner as mentioned above. (7) amylase activity (interfering substance: glucose) short chain amylose EMI18.2 maltose maltose EMI18.3 glucose glucose + 02 2 + H2 0 glucose EMI18.4 gluconic acid + H 202 HO2 + 2-naphtiol (I) EMI18.5 non-coloring substance H 202 + 4-aminoantipyrine + developer EMI18.6 color development (A) First reagent solution buffer solution pH 6 to 8 2-naphthol compound (I) 0.01 to 10 mM peroxidase (POD) 0.1 to 10 units/ml oxidase (i.e. 1 to 100 units/mel glucose oxidase) (B) Second reagent solution buffer solution pH 6 to 8 4-aminoantipyrine 0.1 to 3 mM developer 0.1 to 20 mM substances used as substrates for the enzyme to be determined EMI19.1 short chain amylose 1 to 20 mg/ml (glucose units: 4-6) substance for producing a substrate for the oxidase EMI19.2 a-glucosidase 1 to 100 units/ml A sample is added to the first reagent solution and incubated to decompose the interfering substances, i.e., glucose, in the same manner as mentioned above, followed by addition of the second reagent solution to the resulting mixture and incubation for the colorimetrical determination in the same manner as mentioned above. As mentioned above, substrates or enzyme activities in body fluid samples can be determined quantitatively with high accuracy according to this invention without any influence of interfering substances present in the samples. This invention is illustrated by way of the following Examples. Example 1 [Determination of Trilyceridej (1) Reagent Solutions (A) First reagent solution: 0.05 M tris-HCl buffer solution (pH 6.5) glycerol kinase 15 units/ml glycerol-3-phosphate oxidase 15 units/ml peroxidase 10 units/ml 2-naphthol-7-sulfonic acid 0.5 mM magnesium acetate 5 mM adenosine-5'-triphosphate 6 mM (B) Second reagent solution: 0.05 M tris-HCl buffer solution (pH 6.5) lipoprotein lipase 100 units/ml 4-aminoantipyrine 0.2 mM 3,5 -dimethoxy-N-ethyl- (2-hydroxy-3-sulfopropyl)-. aniline 1 mM (2) Measuring Method To 20 ul of a sample (serum), 1 ml of the first reagent solution was added with well mixing and incubated at 370C for 5 minutes. Subsequently, the second reagent solution was added to the resulting mixture and incubated at 370C for 10 minutes. A reagent blank was prepared in the same manner as mentioned above using 20 ul of distilled water. Absorbance of the serum sample was measured at the wavelength of 600 nm using the reagent blank as control. On the other hand, absorbances of control serum containing known amounts of triglyceride were measured in the same manner as mentioned above. The true content of triglyceride in the serum sample was obtained by proportional calculation containing no error derived from free glycerol in the sample. In order to know an influence of free glycerol on the colorimetrical determination, known amounts of glycerol were added to human serum samples, which were treated in the same manner as mentioned above. The results of the colorimetrical determination are shown in Table 3. As shown in Table 3, no influence of free glycerol on the measurement was admitted. Table 3 EMI22.1 <tb> Run <SEP> Added <SEP> amount <SEP> Measured <SEP> value <tb> No. <SEP> of <SEP> glycerol <SEP> of <SEP> triglyceride <tb> <SEP> (mg/dl) <SEP> (mg/dl) <tb> <SEP> 1 <SEP> 0 <SEP> 186 <tb> <SEP> 2 <SEP> 10 <SEP> 185 <tb> <SEP> 3 <SEP> 20 <SEP> 186 <tb> <SEP> 4 <SEP> 30 <SEP> 186 <tb> <SEP> 5 <SEP> 60 <SEP> 186 <tb> Example 2 (Determination of GPT activity (1) Reagent Solutions (A) First reagent solution: 0.02 M phosphate buffer solution (pH 7.0) pyruvate oxidase 6 units/ml peroxide 10 units/ml thiamine pyrophosphate 0.06% by weight flavin adenine dinucleotide 0.002% by weight magnesium acetate 9 mM 2-naphthol-3-carboxylic acid 0.5 mM (B) Second reagent solution: : 0.02 M phosphate buffer solution (pH 7.0) a-ketoglutaric acid 35 mM DL-alanine 700 mM 4-aminoantipyrine 50 mg/dl 3-methyl-N-ethyl-N (B-hydroxyethyl)-aniline 50 mgidl (C) Reaction stopper solution: 0.05 M phosphate buffer solution (pH 9.0) 2-sodium ethylene diamine tetraacetate 0.05 M 3-sodium citrate 0.1 M (2) Measuring Method To 20 ul of a sample (serum), 0.5 ml of the first reagent solution was added with well mixing and incubated at 370C for 5 minutes. Subsequently, 0.2 ml of the second reagent solution was added to the resulting mixture with well mixing and incubated at just 370C for 20 minutes, followed by addition of 2 ml of the reaction stopper solution. A reagent blank was prepared in the same manner as mentioned above using 20 pl of distilled water. Absorbance of the serum sample was measured at the wavelength of 560 nm using the reagent blank as control. On the other hand, absorbances of control serum having known activities of GPT were measured in the same manner as mentioned above. True GPT activity values in the serum sample were obtained by proportional calculation containing no error derived from free pyruvic acid in the sample. Example 3 tDetermination of GOT activity] (1) Reagent Solutions (A) First reagent solution: 0.02 M phosphate buffer solution (pH 7.0) pyruvate oxidase 6 units/ml peroxidase 10 unitsjml oxaloacetate decarboxylase 10 units/ml thiamine pyrophosphate 0.06% by weight flavin adenine dinucleotide 0.002% by weight magnesium acetate 9 mM 2-naphthol-3-carboxylic acid 0.5 mM (B) Second reagent solution: 0.02 M phosphate buffer solution (pH 70) a-ketoglutaric acid 35 mM L-aspartic acid 280 mM 4-aminoantipyrine 50 mg/dl 3-methyl-N-ethyl-N (B-hydroxyethyl)-aniline 50 mg/dl (C) Reaction stopper solution: : 0.05 M phosphate buffer solution (pH 9.0) 2-sodium ethylenediaminetracetate 0.05 M 3-sodium citrate 0.1 M (2) Measuring Method To 20 p1 of a sample (serum), 0.5 ml of the first reagent solution was added with well mixing and incubated at 370C for 5 minutes. Subsequently, 0.2 ml of the second reagent solution was added to the resulting mixture with well mixing and incubated at just 370C for 20 minutes, followed by addition of 2 ml of the reaction stopper solution. A reagent blank was prepared in the same manner as mentioned above using 20 ul of distilled water. Absorbance of the serum sample was measured at the wavelength of 560 nm using the reagent blank as control. On the other hand, absorbances of control serum having known activities of GOT were measured in the same manner as mentioned above. True GOT activity values in the serum sample were obtained by proportional calculation containing no error derived from pyruvic acid in the sample. Example 4 [Determination of cholesterol ester] (1) Reagent Solutions (A) First reagent solution: 0.10 M phosphate buffer solution (pH 7.0) cholesterol oxidase 0.3 units/ml peroxide 10 units/ml Triton X-100 0.10% by weight 2-naphthol-7-sulfonic acid 0.33 mM (B) Second reagent solution: 0.10 M phosphate buffer solution (pH 7.0) cholesterol esterase 0.3 unit/ml Triton X-100 0.108 by weight 4-aminoantipyrine 30 mg/dl phenol 200 mg/dl Triton X-100 = octyl phenoxy polyethoxyethanol ' lavailable from Rohm and Haas (2) Measuring Method To 20 ul of a sample (serum), 1.5 ml of the first reagent solution was added with well mixing and incubated at 370C for 15 minutes. Subsequently, the second reagent solution was added to the resulting mixture with well mixing and incubated at 370C for 15 minutes. A reagent blank was prepared in the same manner as mentioned above using 20 ul of distilled water. Absorbance of the serum sample was measured at the wavelength of 505 nm using the reagent blank as control. On the other hand, absorbances of control serum containing known amounts of cholesterol ester were measured in the same manner as mentioned above. The true content of cholesterol ester in the serum sample was obtained by proportional calculation containing no error derived from free cholesterol in the sample.

Claims: WHAT IS CLAIMED IS: 1. A process for quantitatively determining a substrate or enzymatic activity in a body fluid sample which comprises adding to a sample to be measured a first reagent solution comprising a compound of the formula: EMI27.1 wherein R1 and R2 are independently hydrogen, a hydroxyl group, carboxyl group or a sulfonic acid group, peroxidase, an oxidase, and if necessary one or more substances used for producing a substrate or used as substrates for the oxidase or used for an enzymatic reaction of a substrate with the oxidase so as to remove an influence of substance in the sample giving an error to the determination, adding to the resulting mixture a second reagent solution comprising a coupler, a developer selected from phenol and derivatives thereof, 1-naphthol and derivatives thereof and aniline and derivatives thereof, and an enzyme necessary for producing the same substance as giving an error to the determination in the case of determining the substrate, or one or more substances used as substrates for the enzyme, the activity of which is to be determined, in the case of determining the enzymatic activity, followed by colorimetrical determination. 2. A process according to Claim 1, wherein the compound of the formula (I) is 2-naphthol, 7-hydroxy-2naphthol, 2-naphthol-7-sulfonic acid, 2-naphthol-3 ,6- disulfonic acid or 2-naphthol-3-carboxylic acid. 3. A process according to Claim 1, wherein the substrate to be determined is triglyceride, the oxidase in the first reagent solution is glycerol-3-phosphate oxidase, the substances for producing a substrate for the oxidase in the first reagent solution are adenosine-5'triphosphate, glycerol kinase and magnesium acetate, and the enzyme necessary for producing the same substance as giving an error to the determination in the second reagent solution is lipoprotein lipase. 4. A process according to Claim 1, wherein the substrate to be determined is cholesterol ester, the oxidase in the first reagent solution is cholesterol oxidase, and the enzyme necessary for producing the same substance as giving an error to the determination in the second reagent solution is cholesterol esterase. 5. A process according to Claim 1, wherein the substrate to be determined is creatine, the oxidase in the first reagent solution is sarcosine oxidase, and the enzyme necessary for producing the same substance as giving an error to the determination in the second reagent solution is creatine amidinohydrase. 6. A process according to Claim 1, wherein the substrate to be determined is creatinine. 7. A process according to Claim 1, wherein the enzyme the activity of which is to be determined is glutamate pyruvate transaminase, the oxidase in the first reagent solution is pyruvate oxidase, the substances used for an enzymatic reaction of a substrate with the oxidase in the first reagent solution are thiamine pyrophosphate and flavin adenine dinucleotide, and the substances used as substrates for the enzyme to be determined are DLalanine and a-ketoglutaric acid. 8. A process according to Claim 1, wherein the enzyme the activity of which is to be determined is glutamate oxaloacetate transaminase, the oxidase in the first reagent solution is pyruvate oxidase, the substance used for producing a substrate for the oxidase in the first reagent solution is oxaloacetate decarboxylase, the substances used for an enzymatic reaction of a substrate for the oxidase are thiamine pyrophosphate and flavin adenine dinucleotide, and the substances used as substrates for the enzyme to be determined are asphartic acid and a-ketoglutaric acid. 9. A process according to Claim 1, wherein the enzyme the activity of which is to be determined is a- amylase, the oxidase in the first reagent solution is glucose oxidase, and the substance used as substrate for the enzyme to be determined is short chain amylose and the substance used for producing a substrate for the oxidase is a-glucosidase.

Inventors: HAMANAKA, TADASHI, KODERA, HIROYUKI, MATSUDA, RYOSUKE, MIYASHITA, YOSHINOBU
Applicants: WAKO PURE CHEMICAL INDUSTRIES, LTD.
Application year: 1984
Main classification: C12Q1
IPC codes: C12Q1